AVO.L Share News (AVO)
AVO Share
AVO Share
AVO Share
AVO Share
AVO
AVO Share
AVO Broker
AVO Directors
AVO Financial
AVO
AVO Short
AVOThu, 17th Dec 2015 10:08
LONDON (Alliance News) - Advanced Oncotherapy PLC Thursday said Non-Executive Director Michael Bradfield bought 750,000 shares at a price of 5.5 pence per share Wednesday.
Following this transaction, Bradfield now holds 122.8 million shares, which represents 8.66% of the issued share capital.
Shares in the medical technology company were up 4.2% at 5.60p Thursday.
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun
Copyright 2015 Alliance News Limited. All Rights Reserved.
(ShareCast News) - Cancer treatment developer Advanced Oncotherapy said it had made good full year progress in developing its 'LIGHT' system, although losses for the full year widened. The company's Geneva-based development team is working on a proprietary proton accelerator called Linac Image Guide
Read more(ShareCast News) - Advanced Oncotherapy has signed a £24m investment agreement with a fund advised by Metric Capital Partners LLP, pushing its shares up more than 7%. Metric Capital will invest the money in a financing facility to support Advanced Oncotherapy's provision of vendor financing for the
Read more(ShareCast News) - Advanced Oncotherapy was moving closer to success with its proton therapy for cancer treatment, updating the market on Tuesday of progress with its proton accelerator programme, dubbed 'LIGHT'. The AIM-traded company said its proton source, which was being constructed by Pantechni
Read more(ShareCast News) - Advanced Oncotherapy has reorganised its executive roles as it focuses on operational functions as well as ongoing sales and business development. The AIM-listed company said its executive chairman Michael Sinclair will have his role expanded to include chief executive officer, wh
Read more